24 research outputs found

    Expression Profiling of Major Histocompatibility and Natural Killer Complex Genes Reveals Candidates for Controlling Risk of Graft versus Host Disease

    Get PDF
    Background: The major histocompatibility complex (MHC) is the most important genomic region that contributes to the risk of graft versus host disease (GVHD) after haematopoietic stem cell transplantation. Matching of MHC class I and II genes is essential for the success of transplantation. However, the MHC contains additional genes that also contribute to the risk of developing acute GVHD. It is difficult to identify these genes by genetic association studies alone due to linkage disequilibrium in this region. Therefore, we aimed to identify MHC genes and other genes involved in the pathophysiology of GVHD by mRNA expression profiling. Methodology/Principal Findings: To reduce the complexity of the task, we used genetically well-defined rat inbred strains and a rat skin explant assay, an in-vitro-model of the graft versus host reaction (GVHR), to analyze the expression of MHC, natural killer complex (NKC), and other genes in cutaneous GVHR. We observed a statistically significant and strong up or down regulation of 11 MHC, 6 NKC, and 168 genes encoded in other genomic regions, i.e. 4.9%, 14.0%, and 2.6% of the tested genes respectively. The regulation of 7 selected MHC and 3 NKC genes was confirmed by quantitative real-time PCR and in independent skin explant assays. In addition, similar regulations of most of the selected genes were observed in GVHD-affected skin lesions of transplanted rats and in human skin explant assays. Conclusions/Significance: We identified rat and human MHC and NKC genes that are regulated during GVHR in skin explant assays and could therefore serve as biomarkers for GVHD. Several of the respective human genes, including HLA-DMB, C2, AIF1, SPR1, UBD, and OLR1, are polymorphic. These candidates may therefore contribute to the genetic risk of GVHD in patients

    The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019

    Get PDF

    Avaliação de rugosidade, dureza e superfície dos cimentos de ionômero de vidro após diferentes sistemas de acabamento e polimento

    No full text
    Resumo Introdução A rugosidade de superfície é uma limitação que interfere nos desempenhos mecânico e estético do cimento de ionômero de vidro (CIV), sendo necessária a utilização de procedimentos para acabamento e polimento adequados às propriedades desse material. Objetivo Avaliar o efeito de diferentes sistemas de acabamento e polimento na rugosidade, dureza e superfície de restaurações realizadas com dois tipos de CIV. Material e método Foram utilizados 100 corpos de prova (CP), divididos em 10 grupos, de acordo com o tipo de CIV (convencional e modificado por resina) e o sistema de acabamento e polimento empregado [C-tira de poliéster (controle); PD-ponta diamantada; DA-discos abrasivos; PE-ponta Enhance; BM-broca multilaminada]. Após sete dias em água destilada, os CP foram avaliados em Microscópio Eletrônico de Varredura (MEV) e submetidos aos testes de rugosidade de superfície e microdureza Vickers. A análise estatística foi realizada com ANOVA dois fatores e pós-Teste de Tukey. Resultado A análise por MEV indicou superfície mais lisa no grupo BM em ambos os tipos de CIV. Quanto à rugosidade, observou-se diferença estatisticamente significante (p<0,05) entre grupos do CIV convencional, mas não houve diferença entre os tipos de CIV. Com relação à dureza, o CIV convencional apresentou melhores resultados que o modificado por resina. No fator materiais de acabamento e polimento, não se verificou diferença estatisticamente significativa, independentemente do tipo de CIV. Conclusão os grupos BM apresentaram melhores resultados ao MEV; o tipo de CIV não influenciou os valores de rugosidade; o tipo de polimento não influenciou a dureza

    Evaluation of radioinduced damage and repair capacity in blood lymphocytes of breast cancer patients

    No full text
    Genetic damage caused by ionizing radiation and repair capacity of blood lymphocytes from 3 breast cancer patients and 3 healthy donors were investigated using the comet assay. The comets were analyzed by two parameters: comet tail length and visual classification. Blood samples from the donors were irradiated in vitro with a 60Co source at a dose rate of 0.722 Gy/min, with a dose range of 0.2 to 4.0 Gy and analyzed immediately after the procedure and 3 and 24 h later. The basal level of damage and the radioinduced damage were higher in lymphocytes from breast cancer patients than in lymphocytes from healthy donors. The radioinduced damage showed that the two groups had a similar response when analyzed immediately after the irradiations. Therefore, while the healthy donors presented a considerable reduction of damage after 3 h, the patients had a higher residual damage even 24 h after exposure. The repair capacity of blood lymphocytes from the patients was slower than that of lymphocytes from healthy donors. The possible influence of age, disease stage and mutations in the BRCA1 and BRCA2 genes are discussed. Both parameters adopted proved to be sensitive and reproducible: the dose-response curves for DNA migration can be used not only for the analysis of cellular response but also for monitoring therapeutic interventions. Lymphocytes from the breast cancer patients presented an initial radiosensitivity similar to that of healthy subjects but a deficient repair mechanism made them more vulnerable to the genotoxic action of ionizing radiation. However, since lymphocytes from only 3 patients and 3 normal subjects were analyzed in the present paper, additional donors will be necessary for a more accurate evaluation
    corecore